Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Alberto Grignolo

Advertisement

Articles by Alberto Grignolo

Patient-Centric Trials in China: An Opportunity to Innovate

ByGeorge Lee,Alberto Grignolo,Rosamund Round,Sy Pretorius,Victor Cheng
June 18th 2019

Pharmaceutical Executive

The opportunities and challenges surrounding patient centricity and patient-centric trials in China.

Advertisement

Latest Updated Articles

  • Patient-Centric Trials in China: An Opportunity to Innovate
    Patient-Centric Trials in China: An Opportunity to Innovate

    June 18th 2019



Advertisement
Advertisement

Trending on PharmExec

1

FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A

2

Understanding the Latest with MFN Pricing and What It Means to Pharma

3

The Battle to Own the GLP-1 Patient Journey

4

Novo Announces Drug Discovery Collaboration with Anthropic

5

Pharmaceutical Executive Daily: FDA Approves Fayuvi

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us